Due to changes made through recent federal rules issued by the Trump administration, small businesses and self-employed business owners can buy health plans through associations that are exempt from many state and federal regulations. These new rules leave consumers without important protections. For example, Association Health Plans (AHPs) don’t have to cover all of the benefits that other plans sold to individual and small businesses must cover.
African Americans Still Lag Behind in Health Outcomes: Increasing Representation Among Providers Must be A Part of the Solution
Black History Month is an opportunity to elevate the accomplishments of African American trailblazers who may be missing from the history books. For example, in health care, we may remember Roselyn Epps, the first black president of the American Medical Women’s Association, or Ida Gray Nelson Rollins, the first black female dentist. We need to continue highlighting individual achievements because inclusive, representative narratives are an important tool for dismantling racism.
African Americans are disproportionately more likely to suffer from mental health issues than white Americans.
In state houses all across the country, advocates, legislators, and state officials are considering proposals to restore the Affordable Care Act’s (ACA’s) temporary reinsurance program, which ended after 2016. This “Reinsurance 101” issue brief describes reinsurance and explains why it was originally included in the ACA. It then analyzes why some advocates and policymakers might consider implementing reinsurance in their states but others could hesitate to pursue such a policy.
On January 17, the Centers for Medicare and Medicaid Services (CMS) published a proposed rule that would raise consumers’ out-of-pocket costs for health care under individual and employer-sponsored health insurance plans, and decrease premium assistance in the individual marketplace.
States’ experience shows that Medicaid expansion at the enhanced federal match can generate state savings across multiple budget areas. Those savings can be substantial, offsetting most or all of the state’s share of expansion costs. A full analysis the budget impact of expanding Medicaid must include an assessment of those savings.
This advocacy agenda offers options for improving health and health care at the state level during the 2019 session. It includes state policy options to consider in 2019 regarding private insurance coverage, Medicaid, oral health coverage, health equity, prescription drugs, surprise medical bills, and health care value.
Throughout our nation’s long and complicated history, the experiences and achievements of past generations of African Americans have formed an indelible part of the tapestry of American life. Their threads are the traditions we embrace during Black History Month. From the life-saving pediatric innovations pioneered at Johns Hopkins by Dr. Vivien Thomas, to the groundbreaking research of Dr.
Maryland's Down Payment Plan: Helping People Get Health Insurance and Lowering Families' Health Costs
Both before and especially after President Trump and his congressional allies ended federal enforcement of the ACA’s individual mandate, several states established their own enforcement systems. Maryland’s lawmakers are proposing an innovative “down payment plan” that uses a more enrollment-oriented approach to requiring people with affordable access to health coverage to obtain insurance. Instead of imposing tax penalties on the uninsured, the Maryland proposal helps the uninsured enroll into coverage whenever possible.
Late last year, the Trump administration released a proposed rule as part of its efforts to lower prescription drug prices that, if finalized, could have a significant impact on Medicare beneficiaries’ ability to access certain drugs under Medicare Part D. Medicare Part D, which covers prescriptions drugs beneficiaries pick up at pharmacies, is administered by private Part D plans. Much like commercial health insurance plans, these Part D plans use formularies to establish which drugs are covered and at what level of beneficiary-cost sharing.